Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell)

Coviccine (Recombinant (sf9) Coronavirus Vaccine) - Sichuan University, WestVac Biopharma

WSK-V102 - WestVac Biopharma

http://clinicaltrials.gov/ct2/show/NCT05770180

Jul 24, 2024